What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Searched for basg.
messages in brief
|
17/04/2014
Austrian "Summaries of Product Characteristics", "Labellings" and "Patient Information Leaflets" should now be submitted via PHAROS eService "Marketing Authorisation & Lifecycle Management of Medicines": https://eservices.basg.gv.at/ . If you are not…
Safety warnings
|
Medicines
|
16/04/2014
The European Medicines Agency received information that vials of Herceptin, a drug used to treat cancer, were adulterated and introduced into the legal distribution chain.
Safety warnings
|
messages in brief
|
16/04/2014
European Medicines Agency warns against counterfeit Herceptin
Safety warnings
|
messages in brief
|
21/02/2014
European Medicines Agency recommends restriction of use of Protelos/Osseor
Safety warnings
|
messages in brief
|
03/02/2014
Prescription of CHCs and importance of individual risk factors.
Safety warnings
|
messages in brief
|
20/12/2013
The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a cytostatic drug from the group of vinca alkaloids and has proven effective primarily in combination…
messages in brief
|
07/10/2013
Policy 0070 on publication and access to clinical-trial data
messages in brief
|
07/10/2013
New management of AGES Medical Market Surveillance
messages in brief
|
01/10/2013
Many medicinal products, when stored appropriately, remain in compliance with their specifications for much longer than can be expected on the basis of their expiration date. If you want to use such stocks of medicinal products safely and…
Safety warnings
|
messages in brief
|
26/07/2013
Metoclopramide-containing medicinal products are approved in a number of Member States in various indications, including nausea and vomiting (for example, after chemotherapy or radiotherapy, surgery, or for migraine) and gastrointestinal motility…